Log In
Print
BCIQ
Print
Print this Print this
 

ARX201

  Manage Alerts
Collapse Summary General Information
Company Ambrx Inc.
DescriptionRecombinant human growth hormone (rhGH) modified by ReCODE technology
Molecular Target Growth hormone receptor
Mechanism of ActionHormone replacement therapy
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationGrowth hormone deficiency
Indication DetailsTreat growth hormone deficiency (GHD); Treat growth hormone deficiency (GHD) in young adults; Treat Treat growth hormone deficiency (GHD) in children
Regulatory Designation
Partner Merck KGaA

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today